What's new

Human medicines European public assessment report (EPAR): Pavblu, aflibercept, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Pavblu, aflibercept, Revision: 1, Status: Authorised

Jun 26, 2025 - 13:50
 0
Human medicines European public assessment report (EPAR): Pavblu, aflibercept, Revision: 1, Status: Authorised
Human medicines European public assessment report (EPAR): Pavblu, aflibercept, Revision: 1, Status: Authorised
Read More

Tags:

Previous Article

STAT+: ADHD medication linked to less impulsive behavior, crashes, and crime

Next Article

Human medicines European public assessment report (EPAR): Phesgo, pertuzumab,tra...

Related Posts

EMEA-003567-PIP01-23

EMEA-003567-PIP01-23

Jun 11, 2025  0

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) – June 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 26 June 2025, 10:00 (CEST) to 26 June 2025, 12:00 (CEST)

Meeting of the Executive Steering Group on Shortages an...

Jun 25, 2025  0

Human medicines European public assessment report (EPAR): LysaKare, arginine,lysine, Date of authorisation: 25/07/2019, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR...

May 21, 2025  0